Megan F. Beaver
Areas of Focus
Overview
Megan F. Beaver is a counsel at Crowell & Moring’s San Francisco office and a member of the firm’s Health Care Group. Her practice focuses on health care regulatory compliance, with a particular emphasis on mental health parity under the Mental Health Parity and Addiction Equity Act (MHPAEA) and related state laws. Megan advises national and regional health plans—including Medicare Advantage, commercial, and Medicaid health plans—on a range of regulatory compliance issues, including state licensure, provider contracting, and delegated entity compliance. She has significant experience supporting clients through Department of Managed Health Care (DMHC) Office of Enforcement investigations and has assisted plans in obtaining licensure under California’s Knox-Keene Health Care Service Plan Act. She also supports health care transactions advising clients on regulatory risks, due diligence, and compliance issues that arise in mergers, acquisitions, and other strategic deals.
Career & Education
- University of the Pacific, McGeorge School of Law, J.D., honor title, 2013
- University of California, Davis, B.A., 2005
- California
Professional Activities and Memberships
- Member, California Bar Association
- Member, American Bar Association
Megan's Insights
Client Alert | 3 min read | 07.08.25
DOJ and HHS Launch FCA Working Group: Heightened Enforcement Risk for Health Care Entities
On July 2, 2025, the U.S. Department of Justice (DOJ) Civil Division and the U.S. Department of Health and Human Services (HHS) jointly announced the formation of a False Claims Act (FCA) Working Group. This new initiative underscores a coordinated federal enforcement strategy focused on identifying and addressing fraud in federally funded health care programs, particularly Medicare Advantage and Medicaid managed care. The announcement comes days after Matthew R. Galeotti, Head of DOJ’s Criminal Division, announced the results of the “largest coordinated health care fraud takedown in the history of the Department of Justice” and the creation of a “Health Care Fraud Data Fusion Center” comprised of data specialists that will “break down information silos, using coordinated data analysis to enable our investigative teams to quickly identify and dismantle emerging fraud schemes.” Taken together, these announcements demonstrate the DOJ’s effort—in both civil and criminal divisions—to strengthen its collaboration with HHS to investigate and prosecute health care fraud.
Client Alert | 3 min read | 05.16.25
Trump Administration Pauses Enforcement of the MHPAEA Final Rule
Podcast | 02.20.25
Payers, Providers, and Patients – Oh My!: Gender-Affirming Care
Client Alert | 4 min read | 01.23.25
Tri-Agencies Release Third Mental Health Parity Report to Congress
Representative Matters
- Defended California health care service plan in arbitration regarding payment of out-of-network services.
- Represented Medi-Cal county organized health system in state fair hearings before the California Department of Social Services.
- Represented Medi-Cal managed care plan in the California Superior Court on a writ of mandate related to the denial of Medi-Cal benefits.
- Defended California health care services plan in arbitration with a health care provider over application of contractual language related to claims editing and payment.
Megan's Insights
Client Alert | 3 min read | 07.08.25
DOJ and HHS Launch FCA Working Group: Heightened Enforcement Risk for Health Care Entities
On July 2, 2025, the U.S. Department of Justice (DOJ) Civil Division and the U.S. Department of Health and Human Services (HHS) jointly announced the formation of a False Claims Act (FCA) Working Group. This new initiative underscores a coordinated federal enforcement strategy focused on identifying and addressing fraud in federally funded health care programs, particularly Medicare Advantage and Medicaid managed care. The announcement comes days after Matthew R. Galeotti, Head of DOJ’s Criminal Division, announced the results of the “largest coordinated health care fraud takedown in the history of the Department of Justice” and the creation of a “Health Care Fraud Data Fusion Center” comprised of data specialists that will “break down information silos, using coordinated data analysis to enable our investigative teams to quickly identify and dismantle emerging fraud schemes.” Taken together, these announcements demonstrate the DOJ’s effort—in both civil and criminal divisions—to strengthen its collaboration with HHS to investigate and prosecute health care fraud.
Client Alert | 3 min read | 05.16.25
Trump Administration Pauses Enforcement of the MHPAEA Final Rule
Podcast | 02.20.25
Payers, Providers, and Patients – Oh My!: Gender-Affirming Care
Client Alert | 4 min read | 01.23.25
Tri-Agencies Release Third Mental Health Parity Report to Congress
Insights
Tri-Agencies Finalize NQTL Comparative Analysis Standards In Final Rule
|12.23.24
Employee Benefit Plan Review
HHS Aims to Strengthen Anti-Discrimination Rules for Disabled Patients in New Proposed Rule
|10.18.23
Crowell & Moring’s Health Law Blog
Megan's Insights
Client Alert | 3 min read | 07.08.25
DOJ and HHS Launch FCA Working Group: Heightened Enforcement Risk for Health Care Entities
On July 2, 2025, the U.S. Department of Justice (DOJ) Civil Division and the U.S. Department of Health and Human Services (HHS) jointly announced the formation of a False Claims Act (FCA) Working Group. This new initiative underscores a coordinated federal enforcement strategy focused on identifying and addressing fraud in federally funded health care programs, particularly Medicare Advantage and Medicaid managed care. The announcement comes days after Matthew R. Galeotti, Head of DOJ’s Criminal Division, announced the results of the “largest coordinated health care fraud takedown in the history of the Department of Justice” and the creation of a “Health Care Fraud Data Fusion Center” comprised of data specialists that will “break down information silos, using coordinated data analysis to enable our investigative teams to quickly identify and dismantle emerging fraud schemes.” Taken together, these announcements demonstrate the DOJ’s effort—in both civil and criminal divisions—to strengthen its collaboration with HHS to investigate and prosecute health care fraud.
Client Alert | 3 min read | 05.16.25
Trump Administration Pauses Enforcement of the MHPAEA Final Rule
Podcast | 02.20.25
Payers, Providers, and Patients – Oh My!: Gender-Affirming Care
Client Alert | 4 min read | 01.23.25
Tri-Agencies Release Third Mental Health Parity Report to Congress
